Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  pyridoxine hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-20 of 20 for your search:
Start Over
Phase III CTX/ADR/VCR Therapy Alone or with Radiotherapy Followed by VP-16/HMM or MTX/CF/VP-16/HMM for Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: SEG-78LUN328
Phase III Pilot Intensification with High-Dose ARA-C and Consolidation with MACHO (CTX/ADR/VCR/PRED/MTX/L-ASP) for Adult ALL
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: EST-2483
Phase III Chemotherapy with HMM and High-Dose vs Low-Dose CACP, with or without VIT-B6, for Stage III/IV Ovarian Cancer (Summary last modified 06/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2879R
Phase III CACP/CTX vs HMM for Residual, non-Measurable Stage III Ovarian Adenocarcinoma Responsive to Prior CACP/CTX
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-61
Phase III Chemotherapy with High-Dose ARA-C/AMSA and Low-Dose ARA-C for Maintenance vs No Maintenance Therapy for Adult ANLL
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: EST-5483
Phase III Vitamin Therapy with Pyridoxine for Resected Transitional Cell Tumors of the Bladder
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-30781
Phase III Adjuvant Therapy for Dukes' Stage C Adenocarcinoma of the Colon: Protracted Infusional 5-FU plus LEV vs Bolus 5-FU plus LEV (Summary Last Modified 03/91)
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAOP-5186A, NCI-V90-0196
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CASE5Y03, P30CA043703, NCT00245050
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000464246, NCCTG-N05C5, ROCHE-NCCTG-N05C5, N05C5, NCT00296036
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0553C, NCI-2012-00946, NCT00659269
Phase I/II Pilot Study of Intensive Consolidation with High-Dose ARA-C/AMSA After Induction with DNM/ARA-C/TG for ANLL in Adults
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 to 70
Sponsor: NCI
Protocol IDs: EST-PB-482
Phase II Chemotherapy with VP-16/PCB/HMM for Small Cell Carcinoma of the Lung
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-053-161
Phase II Pilot Study of High-Dose ARA-C plus AMSA in Adults with Acute Nonlymphocytic Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: EST-PC-482
Phase II Chemotherapy with MITO/HMM/DAVA for Inoperable non-Small Cell Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor: NCI
Protocol IDs: EST-PD-580
Phase II Master Protocol and Chemotherapy with VM-26/PRED Plus cis-Platinum or Hexamethylmelamine for Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 to 76
Sponsor: NCI
Protocol IDs: EST-1478
Phase I Study of Taxol/HMM in Patients with Refractory or Residual Ovarian Cancer
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-92HO043, NCI-T92-0014D, T92-0014
Start Over